Buspirone attenuates volitional alcohol intake in the chronically drinking monkey.

No abstract is available for this paper.

• Publication year

  1987

• Venue

  Alcohol

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1016/0741-8329(87)90060-7PMID 3828064
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effects of chlordiazepoxide on schedule-induced water and alcohol consumption in the squirrel monkey

  2004cited by this paper
• Tetrahydro-β-carboline micro-injected into the hippocampus induces an anxiety-like state in the rat

  1986cited by this paper
• Antagonism by naltrexone of voluntary alcohol selection in the chronically drinking macaque monkey.

  1986cited by this paper
• Alcohol and biological membranes

  1985cited by this paper
• Neuropharmacological antagonism of the beta-carboline-induced "anxiety" response in rhesus monkeys

  1985cited by this paper
• Pharmacological and clinical effects of buspirone.

  1985cited by this paper
• Ethanol’s Action on Brain Biochemistry

  1985cited by this paper
• Monoaminergic involvement in the pharmacological actions of buspirone

  1985cited by this paper
• Chlordiazepoxide's interaction with ethanol intake in the rat: relation to ethanol exposure paradigms.

  1984cited by this paper
• Buspirone as a midbrain modulator: Anxiolysis unrelated to traditional benzodiazepine mechanisms

  1984cited by this paper
• Effects of combined alcohol and benzodiazepine: a review.

  1984cited by this paper
• The suppression of ethanol self injection by buprenorphine.

  1983cited by this paper
• Influence of chlordiazepoxide on alcohol consumption in mice.

  1983cited by this paper
• Buspirone: an anxioselective alternative for the management of anxiety disorders.

  1983cited by this paper
• Attenuation of alcohol drinking in tetrahydroisoquinoline-treated rats by morphine and naltrexone.

  1983cited by this paper
• Pharmacology and neurochemistry of buspirone.

  1982cited by this paper
• Pharmacology of antidepressants in use in the United States.

  1982cited by this paper
• A double-blind comparison of buspirone and diazepam in outpatients with generalized anxiety disorder.

  1982cited by this paper
• Buspirone: multicenter efficacy study.

  1982cited by this paper
• Alcohol drinking in the rat: increases following intracerebroventricular treatment with tetrahydro-beta-carbolines.

  1982cited by this paper
• Buspirone and diazepam in anxiety: a controlled study.

  1982cited by this paper
• Comparison of buspirone in two separate studies.

  1982cited by this paper
• Alcohol drinking induced in the monkey by tetrahydropapaveroline (THP) infused into the cerebral ventricle.

  1982cited by this paper
• Effects of chronically administered buspirone and diazepam on driving-related skills performance.

  1982cited by this paper
• Naloxone alters alcohol drinking induced in the rat by tetrahydropapaveroline (THP) infused ICV.

  1982cited by this paper
• Effects of buspirone on operant behavior of laboratory rats and cynomolgus monkeys.

  1982cited by this paper
• Buspirone: chemical profile of a new class of anxioselective agents.

  1982cited by this paper
• The comparative efficacy of buspirone and diazepam in the treatment of anxiety.

  1979cited by this paper
• Psychopharmacology of alcohol.

  1978cited by this paper
• Alcohol drinking in the rat induced by acute intra-cerebral infusion of two tetrahydroisoquinolines and a beta-carboline.

  1977cited by this paper
• Chapter 10 – Chronic Methods: Intraventricular Infusion, Cerebrospinal Fluid Sampling, and Push-Pull Perfusion

  1977cited by this paper
• Diencephalic efflux of calcium ions in the monkey during exercise, thermal stress and feeding

  1977cited by this paper
• Differential actions on voluntary alcohol intake of tetrahydroisoquinolines or a beta-carboline infused chronically in the ventricle of the rat.

  1977cited by this paper
• Genetic differences in ethanol drinking of the rat following injection of 6-OHDA, 5,6-DHT or 5,7-DHT into the cerebral ventricles.

  1976cited by this paper
• Preference for ethanol in the rhesus monkey following chronic infusion of ethanol into the cerebral ventricles.

  1972cited by this paper
• Methods for Perfusing Different Structures of the Brain

  1972cited by this paper
• Alcohol Preference in the Rat: Reduction Following Depletion of Brain Serotonin

  1968cited by this paper
• Voluntary Alcohol Consumption in Animals: Peripheral and Intracerebral Factors

  1966cited by this paper
• Intraclass Correlation and the Analysis of Variance

  1958cited by this paper

• Neural serotonergic circuits for controlling long-term voluntary alcohol consumption in mice

  2022cites this paper
• Receptors and Channels Associated with Alcohol Use: Contributions from Drosophila

  2021cites this paper
• Aggressive temperament predicts ethanol self-administration in late adolescent male and female rhesus macaques

  2016cites this paper
• Pharmacological Approaches to the Treatment of Alcohol Dependence in the Young

  2014cites this paper
• Interactions of a Dopamine D1 Receptor Agonist with Glutamate NMDA Receptor Antagonists on the Volitional Consumption of Ethanol by the mHEP Rat

  2013cites this paper
• 5-HT1A Partial Agonists

  2012cites this paper
• Role of the serotonergic system in alcohol dependence: from animal models to clinics.

  2011cites this paper
• Pharmacotherapy for Alcoholism and Some Related Psychiatric and Addictive Disorders: Scientific Basis and Clinical Findings

  2010cites this paper
• GENETICS AND CELL BIOLOGY 5-HT1A Receptors in the Frontal Cortical Brain Areas in Cloninger Type 1 and 2 Alcoholics Measured by Whole-Hemisphere Autoradiography

  2009cites this paper
• 5-HT(1A) receptors in the frontal cortical brain areas in Cloninger type 1 and 2 alcoholics measured by whole-hemisphere autoradiography.

  2008cites this paper
• Update on neuropharmacological treatments for alcoholism: scientific basis and clinical findings.

  2008cites this paper
• Preclinical and clinical pharmacology of alcohol dependence

  2007cites this paper
• Morphometry of dorsal raphe nucleus serotonergic neurons in alcoholism.

  2007cites this paper
• The relation of free plasma tryptophan to anger, hostility, and aggression in a nonpatient sample of adult men and women

  2006cites this paper
• Effects of buspirone and gepirone on IV cocaine self-administration in rhesus monkeys

  2005cites this paper
• Serotonergic compounds: clinical data

  2005cites this paper
• Role of the Serotonergic System in the Neurobiology of Alcoholism

  2004cites this paper
• Intercellular metabolic compartmentation in the brain: past, present and future.

  2004cites this paper
• [Pharmacological treatment of substance dependence from a neuroscientific perspective (II): alcohol, benzodiazepines and nicotine].

  2003cites this paper
• The role of serotonergic agents as treatments for alcoholism.

  2003cites this paper
• The pre-clinical behavioural pharmacology of 3,4-methylenedioxymethamphetamine (MDMA).

  2003cites this paper
• The status of serotonin-selective pharmacotherapy in the treatment of alcohol dependence.

  2003cites this paper
• Gamma-aminobutyric acid(GABA)Receptors

  2003cites this paper
• Utilização do acamprosato no tratamento de dependentes de álcool

  2002cites this paper
• Neuropharmacological treatments for alcoholism: scientific basis and clinical findings

  2000cites this paper
• A review of the role of serotonin receptors in psychiatric disorders

  2000cites this paper
• Does Socioeconomic Status Relate to Central Serotonergic Responsivity in Healthy Adults?

  2000cites this paper
• A Low Protein, High Carbohydrate Diet Attenuates Alcohol Intake in Rats.

  1999cites this paper
• Negative affect and voluntary alcohol consumption in Wistar-Kyoto (WKY) and Sprague-Dawley rats.

  1999cites this paper
• Discriminative stimulus effects of ethanol: neuropharmacological characterization.

  1999cites this paper
• Oral ethanol self-administration in rhesus monkeys: behavioral and neurochemical correlates.

  1999cites this paper
• Buspirone treatment of alcoholism: age of onset, and cerebrospinal fluid 5-hydroxyindolacetic acid and homovanillic acid concentrations, but not medication treatment, predict return to drinking.

  1999cites this paper
• Drug therapy for alcohol dependence.

  1999cites this paper
• Nefazodone attenuates the behavioral and neurochemical effects of ethanol.

  1998cites this paper
• Naltrexone and amperozide modify chocolate and saccharin drinking in high alcohol-preferring P rats.

  1998cites this paper
• Limited access to ethanol in genetic drinking rats is suppressed while feeding is enhanced by the mixed 5-HT1A agonist/5-HT2A antagonist FG5938.

  1998cites this paper
• Serotonergic receptors modify the voluntary intake of alcohol and morphine but not of cocaine and nicotine by rats.

  1997cites this paper
• Toward a definition of a valid model of alcoholism: multiple animal models for multiple diseases.

  1997cites this paper
• S 15535, a novel benzodioxopiperazine ligand of serotonin (5-HT)1A receptors: II. Modulation of hippocampal serotonin release in relation to potential anxiolytic properties.

  1997cites this paper
• Relapse Prevention in Alcoholism

  1997cites this paper
• Sexual behavior in same-sexed nonhuman primates: is it relevant to understanding human homosexuality?

  1997cites this paper
• Buspirone as an inhibitor of voluntary ethanol intake in male rats.

  1996cites this paper
• Serotonin receptors and their function in sleep, anxiety disorders and depression.

  1996cites this paper
• Buspirone in the treatment of alcohol dependence: a placebo-controlled trial.

  1996cites this paper
• Efficacy of buspirone in alcohol dependence: a review.

  1996cites this paper
• Lesioning of midbrain raphe nuclei with 5,7-DHT fails to alter ethanol intake in the low alcohol drinking (LAD) rat.

  1996cites this paper
• Recent developments in the pharmacotherapy of alcohol dependence.

  1996cites this paper
• Differential efficacy of serotonergic drugs FG5974, FG5893, and amperozide in reducing alcohol drinking in P rats.

  1996cites this paper
• The mixed 5-HT 1A/2A receptor drug FG5938 suppresses alcohol drinking while enhancing feeding in P rats.

  1996cites this paper
• Evaluation and treatment of anxiety symptoms and disorders in alcoholics.

  1996cites this paper
• Alcohol intake in high alcohol drinking (HAD) rats is suppressed by FG5865, a novel 5-HT1A agonist/5-HT2 antagonist.

  1996cites this paper
• FG5893: A Potential New Generation Anxiolytic/Antidepressant Drug with High Affinity for 5-HT1A and 5-HT2A Receptors

  1996cites this paper
• 5-HT Mediation of Alcohol Self-Administration, Tolerance and Dependence: Pre-Clinical Studies

  1995cites this paper
• Chronic alcoholization alters the expression of 5-HT1A and 5-HT1B receptor subtypes in rat brain.

  1995cites this paper
• Buspirone treatment of anxious alcoholics: A placebo-controlled trial

  1995cites this paper
• Clinical Application of Findings from Animal Research on Alcohol Self-Administration and Dependence

  1995cites this paper
• Biochemical pharmacology of serotonin receptor subtypes: hypotheses for clinical applications of selective serotonin ligands

  1995cites this paper
• Neurotransmitter and neuromodulatory mechanisms involved in alcohol abuse and alcoholism.

  1995cites this paper
• Neurobehavioral aspects of the pharmacotherapy of alcohol dependence.

  1995cites this paper
• Suppression of alcohol consumption by fenfluramine in Fawn-Hooded rats with serotonin dysfunction.

  1994cites this paper
• Serotonin and alcohol intake, abuse, and dependence: findings of animal studies.

  1994cites this paper
• Buspirone treatment of anxious alcoholics. A placebo-controlled trial.

  1994cites this paper
• Alcohol drinking in rats treated with 5,7-dihydroxytryptamine: effect of 8-OH-DPAT and tropisetron (ICS 205-930).

  1994cites this paper
• Influence of the 5-HT1A receptor agonist ipsapirone on voluntary alcohol intake in rats.

  1994cites this paper
• Current concepts of ethanol dependence.

  1994cites this paper
• Psychological correlates of frequency and type of drug use among jail inmates.

  1994cites this paper
• Implications of recent neuropsychopharmacologic research for understanding the etiology and development of alcoholism.

  1994cites this paper
• New drugs for the treatment of experimental alcoholism.

  1994cites this paper
• Serotonin receptors‐where are they going?

  1994cites this paper
• Effects of various serotonergic agents on alcohol intake and alcohol preference in Wistar rats selected at two different levels of alcohol preference.

  1993cites this paper
• Role of serotonin in ethanol abuse

  1993cites this paper
• Reducing the desire to drink. Pharmacology and neurobiology.

  1993cites this paper
• Suppression of opiate withdrawal and cocaine hyperarousal syndromes by buspirone. Possible pharmacotherapeutic applications.

  1993cites this paper
• Ipsapirone and 8-OH-DPAT reduce ethanol preference in rats: involvement of presynaptic 5-HT1A receptors

  1993cites this paper
• Alcohol drinking in rats is attenuated by the mixed 5-HT1 agonist/5-HT2 antagonist FG 5893.

  1993cites this paper
• Irreversible suppression of alcohol drinking in cyanamide-treated rats after sustained delivery of the 5-HT2 antagonist amperozide.

  1993cites this paper
• Effect of drugs influencing 5-HT function on ethanol drinking and feeding behaviour in rats: studies using a drinkometer system.

  1992cites this paper
• Selective reduction by the 5-HT antagonist amperozide of alcohol preference induced in rats by systemic cyanamide.

  1992cites this paper
• A placebo-controlled trial of buspirone in anxious inpatient alcoholics.

  1992cites this paper
• Pharmacological treatment of alcoholism.

  1992cites this paper
• Serotonergic and dopaminergic involvement in ethanol intake.

  1992cites this paper
• Effects of 5-HT-1A receptor agonists on ethanol preference in the rat.

  1992cites this paper
• Attenuation of alcohol consumption by MDMA (ecstasy) in two strains of alcohol-preferring rats.

  1992cites this paper
• Voluntary Intake of Alcohol Is Attenuated by Ipsapirone in Mice and Role of 5–HT1A Receptor

  1992cites this paper
• Research Advances in Pharmacotherapy for Alcoholism

  1992cites this paper
• Effects of gepirone on ethanol consumption, exploratory behavior, and motor performance in rats

  1992cites this paper
• Ritanserin, a new therapeutic approach for drug abuse. Part 1: Effects on alcohol

  1991cites this paper
• Buspirone: A Worldwide Update

  1991cites this paper
• Pharmacotherapies for alcoholism: promising agents and clinical issues.

  1991cites this paper
• Effect of calcium-channel blockers on alcohol consumption in alcohol-drinking monkeys.

  1991cites this paper
• 5-HT1A partial agonists. What is their future?

  1991cites this paper
• Neurodynamics of relapse prevention: a neuronutrient approach to outpatient DUI offenders.

  1990cites this paper
• Neuropsychiatric disorders and the multiple human brain serotonin receptor subtypes and subsystems.

  1990cites this paper
• Higher density of serotonin-1A receptors in the hippocampus and cerebral cortex of alcohol-preferring P rats.

  1990cites this paper
• An open trial of buspirone in alcoholics.

  1989cites this paper
• Effects of the 5-HT receptor agonist, 8-OH-DPAT, on ethanol preference in the rat.

  1989cites this paper
• Buspirone in the treatment of alcoholic patients.

  1989cites this paper
• Isoquinolines, beta-carbolines and alcohol drinking: Involvement of opioid and dopaminergic mechanisms

  1989cites this paper
• Serotonergic Mechanisms in Alcohol Intake

  1989cites this paper
• Buspirone alters alcohol drinking induced in rats by tetrahydropapaveroline injected into brain monoaminergic pathways.

  1988cites this paper